Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Ilya Ayzenberg, Robert Hoepner, Ingo Kleiter Department of Neurology, St Josef Hospital, Ruhr University Bochum, Bochum, Germany Abstract: Fingolimod (FTY720), an immunotherapeutic drug targeting the sphingosine-1-phosphate receptor, is a widely used medication for relapsing-remitting multiple scl...

Full description

Bibliographic Details
Main Authors: Ayzenberg I, Hoepner R, Kleiter I
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Immunotherapy
Bradycardia
Progressive multifocal leukoencephalopathy
Neuroprotection
Stroke
Alzheimer´s disease
Online Access:https://www.dovepress.com/fingolimod-for-multiple-sclerosis-and-emerging-indications-appropriate-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/fingolimod-for-multiple-sclerosis-and-emerging-indications-appropriate-peer-reviewed-article-TCRM

Similar Items